You may be entitled to compensation if you were diagnosed with CTCL after using Dupixent. See if you qualify.
Recent studies and reports have revealed a concerning link between Dupixent use and the development of serious cancers, particularly CTCL (Cutaneous T-Cell Lymphoma).
Studies suggest Dupixent may significantly increase the risk of Cutaneous T-Cell Lymphoma, a serious form of skin cancer.
Patients and doctors may not have been properly warned about these serious cancer risks before prescribing or taking Dupixent.
Thousands of patients who trusted this medication may now be facing life-threatening cancer diagnoses and expensive treatments.
Cutaneous T-Cell Lymphoma (CTCL) is a type of non-Hodgkin's lymphoma that primarily affects the skin. It can cause severe skin lesions, itching, and in advanced stages, can spread to lymph nodes and internal organs. Treatment is often complex, expensive, and may require ongoing medical care.
Failure to Warn: Inadequate warnings about cancer risks
Defective Design: The drug may be unreasonably dangerous
Negligence: Failure to conduct adequate safety testing
Breach of Warranty: The drug didn't perform as promised
Legal action is being taken against Sanofi and Regeneron because evidence suggests they may have known about the cancer risks associated with Dupixent but failed to adequately warn patients and healthcare providers.
Pharmaceutical companies have a legal duty to thoroughly test their drugs and provide clear warnings about serious side effects. When they fail to do so, they can be held liable for the harm caused to patients.
The lawsuits allege that if patients had been properly warned about the cancer risks, they could have made informed decisions about their treatment options.
If you used Dupixent and developed cancer or other serious side effects, you may be entitled to significant compensation for your suffering.
Recover damages for medical bills, lost wages, pain and suffering
Help prevent future harm by holding manufacturers responsible
Join thousands of others seeking justice for Dupixent-related harm
Legal deadlines may limit your ability to file a claim
Every state has strict time limits for filing legal claims. If you wait too long, you may lose your right to seek compensation forever.
If you used Dupixent and were later diagnosed with CTCL, lymphoma, or other serious side effects, you may have a valid legal claim. Our free case review will help determine if you qualify for compensation.
Nothing upfront. We work on a contingency fee basis, which means you don't pay attorney fees unless we successfully recover compensation for you. The case review is completely free with no obligation.
The timeline varies depending on the complexity of your case and whether it settles or goes to trial. Mass tort cases can take anywhere from months to several years.
You should never stop taking prescribed medication without consulting your doctor. However, you can still pursue legal action for harm you've already suffered while continuing necessary medical treatment.
Absolutely. All information you provide is protected by attorney-client privilege and will be kept strictly confidential.
Don't let pharmaceutical companies profit from your suffering. Get the justice and compensation you deserve.
By clicking the “Submit My Claim” button, you certify that you have provided your legal name and your own phone number, you agree to the Terms and Conditions and Privacy Policy and authorize DupixentCaseReview and its partners to contact you by email or at the phone number you entered using automated technology including recurring auto-dialers, pre-recorded messages, and text messages, even if your phone is a mobile number or is currently listed on any state, federal, or corporate “Do Not Call” list. You understand that your telephone company may impose charges on you for these contacts, and that you can revoke this consent at any time. For SMS campaigns Text STOP to cancel and HELP for help. Message and data rates may apply. By clicking the “Submit My Claim” button and submitting this form, I affirm that I have read and agree to this Site’s Terms and Conditions (including the arbitration provision and the E-SIGN consent) and Privacy Policy and agree to receive email from DupixentCaseReview and affiliated brands that may be of interest to you.
Prefer not to wait? You can speak directly with a case specialist now.
